Published 11/03/2009 by TheStockAdvisors.com
Gilead (GILD): 4-in-1 HIV drug
" Gilead Sciences (NASDAQ: GILD ) develops treatments for life-threatening diseases and specializes in drugs for HIV, the virus that causes AIDS," notes Hannah Choe .
The contributing editor to Personal Finance explains, "Already the market leader in HIV antivirals, Gilead...
Share this
There are no more reports on this story yet.